Medication (English Wikipedia)

Kowalksy SP (2013). "Patent Landscape Analysis of Healthcare Innovations" (PDF). The Franklin Pierce Center for Intellectual Property. University of New Hampshire School of Law. Archived from the original (PDF) on 4 March 2016.

acs.org (Global: 865^th place; English: 887^th place)

pubs.acs.org

Stork W (20 June 2005). "Top Pharmaceuticals: Prontosil". Chemical & Engineering News. Vol. 83, no. 25. Archived from the original on 13 October 2008. Retrieved 30 May 2014.
Gadipelly C, Pérez-González A, Yadav GD, et al. (23 July 2014). "Pharmaceutical Industry Wastewater: Review of the Technologies for Water Treatment and Reuse". Industrial & Engineering Chemistry Research. 53 (29): 11571–11592. doi:10.1021/ie501210j. ISSN 0888-5885.

adsabs.harvard.edu (Global: 14^th place; English: 9^th place)

ui.adsabs.harvard.edu

Steven M. Paul, Daniel S. Mytelka, Christopher T. Dunwiddie, et al. (2010). "How to improve R&D productivity: the pharmaceutical industry's grand challenge". Nature Reviews Drug Discovery. 9 (3): 203–214. Bibcode:2010NRvDD...9..203P. doi:10.1038/nrd3078. PMID 20168317. S2CID 1299234.
Scannell JW, Blanckley A, Boldon H, et al. (1 March 2012). "Diagnosing the decline in pharmaceutical R&D efficiency". Nature Reviews Drug Discovery. 11 (3): 191–200. Bibcode:2012NRvDD..11..191S. doi:10.1038/nrd3681. ISSN 1474-1776. PMID 22378269. S2CID 3344476.
Richmond EK, Grace MR, Kelly JJ, et al. (1 January 2017). "Pharmaceuticals and personal care products (PPCPs) are ecological disrupting compounds (EcoDC)". Elementa: Science of the Anthropocene. 5 66. Bibcode:2017EleSA...5Q..66R. doi:10.1525/elementa.252. ISSN 2325-1026.
Liu JL, Wong MH (1 September 2013). "Pharmaceuticals and personal care products (PPCPs): A review on environmental contamination in China". Environment International. 59: 208–224. Bibcode:2013EnInt..59..208L. doi:10.1016/j.envint.2013.06.012. ISSN 0160-4120. PMID 23838081.
Anand U, Adelodun B, Cabreros C, et al. (1 December 2022). "Occurrence, transformation, bioaccumulation, risk and analysis of pharmaceutical and personal care products from wastewater: a review". Environmental Chemistry Letters. 20 (6): 3883–3904. Bibcode:2022EnvCL..20.3883A. doi:10.1007/s10311-022-01498-7. ISSN 1610-3661. PMC 9385088. PMID 35996725.

britannica.com (Global: 37^th place; English: 64^th place)

"Medication Definition & Meaning". Britannica Dictionary. Archived from the original on 31 March 2022. Retrieved 31 March 2022.

cancer.gov (Global: 1,906^th place; English: 1,649^th place)

"Definition of medication". National Cancer Institute. 2 February 2011. Archived from the original on 29 November 2022. Retrieved 24 November 2022.

cnn.com (Global: 36^th place; English: 26^th place)

"In cancer drug battle, both sides appeal to ethics". CNN. 20 September 2013. Archived from the original on 25 December 2013. Retrieved 24 December 2013.

doi.org (Global: 2^nd place; English: 2^nd place)

Qato DM, Wilder J, Schumm L, et al. (1 April 2016). "Changes in prescription and over-the-counter medication and dietary supplement use among older adults in the united states, 2005 vs 2011". JAMA Internal Medicine. 176 (4): 473–482. doi:10.1001/jamainternmed.2015.8581. PMC 5024734. PMID 26998708.
Steven M. Paul, Daniel S. Mytelka, Christopher T. Dunwiddie, et al. (2010). "How to improve R&D productivity: the pharmaceutical industry's grand challenge". Nature Reviews Drug Discovery. 9 (3): 203–214. Bibcode:2010NRvDD...9..203P. doi:10.1038/nrd3078. PMID 20168317. S2CID 1299234.
Taylor D (2015). "The Pharmaceutical Industry and the Future of Drug Development". Pharmaceuticals in the Environment. Issues in Environmental Science and Technology. pp. 1–33. doi:10.1039/9781782622345-00001. ISBN 978-1-78262-189-8.
Dean B, Barber N, Schachter M (December 2000). "What is a prescribing error?". Qual Health Care. 9 (4): 232–7. doi:10.1136/qhc.9.4.232. PMC 1743540. PMID 11101708.
Kesselheim AS, Avorn J, Sarpatwari A (23 August 2016). "The High Cost of Prescription Drugs in the United States". JAMA. 316 (8): 858–71. doi:10.1001/jama.2016.11237. PMID 27552619. S2CID 19317308.
Scannell JW, Blanckley A, Boldon H, et al. (1 March 2012). "Diagnosing the decline in pharmaceutical R&D efficiency". Nature Reviews Drug Discovery. 11 (3): 191–200. Bibcode:2012NRvDD..11..191S. doi:10.1038/nrd3681. ISSN 1474-1776. PMID 22378269. S2CID 3344476.
Dowling HF (June 1972). "Frustration and foundation. Management of pneumonia before antibiotics". JAMA. 220 (10): 1341–5. doi:10.1001/jama.1972.03200100053011. PMID 4553966.
Everett N, Gabra M (8 August 2014). "The pharmacology of medieval sedatives: the "Great Rest" of the Antidotarium Nicolai". Journal of Ethnopharmacology. 155 (1): 443–449. doi:10.1016/j.jep.2014.05.048. ISSN 1872-7573. PMID 24905867.
Helene S (2010). "EU Compassionate Use Programmes (CUPs): Regulatory Framework and Points to Consider before CUP Implementation". Pharm Med. 24 (4): 223–229. doi:10.1007/bf03256820. S2CID 31439802.
Phillips L (4 September 2008). "Contract Law and Ethical Issues Underscore the Latest Lawsuit About Access to Experimental Drugs for Duchenne Muscular Dystrophy". Neurology Today. 8 (17): 20–21. doi:10.1097/01.nt.0000337676.20893.50.
Banta D.H. (2001). "Worldwide Interest in Global Access to Drugs". Journal of the American Medical Association. 285 (22): 2844–46. doi:10.1001/jama.285.22.2844-JMN0613-3-1. PMID 11401589.
Barton J.H., Emanuel E.J. (2005). "The Patents-Based Pharmaceutical Development Process: Rationale, Problems and Potential Reforms". Journal of the American Medical Association. 294 (16): 2075–82. doi:10.1001/jama.294.16.2075. PMID 16249422. S2CID 10277752.
Richmond EK, Grace MR, Kelly JJ, et al. (1 January 2017). "Pharmaceuticals and personal care products (PPCPs) are ecological disrupting compounds (EcoDC)". Elementa: Science of the Anthropocene. 5 66. Bibcode:2017EleSA...5Q..66R. doi:10.1525/elementa.252. ISSN 2325-1026.
Ebele AJ, Abou-Elwafa Abdallah M, Harrad S (1 March 2017). "Pharmaceuticals and personal care products (PPCPs) in the freshwater aquatic environment". Emerging Contaminants. 3 (1): 1–16. doi:10.1016/j.emcon.2016.12.004. ISSN 2405-6650.
Patel M, Kumar R, Kishor K, et al. (27 March 2019). "Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods". Chemical Reviews. 119 (6): 3510–3673. doi:10.1021/acs.chemrev.8b00299. ISSN 0009-2665. PMID 30830758.
Liu JL, Wong MH (1 September 2013). "Pharmaceuticals and personal care products (PPCPs): A review on environmental contamination in China". Environment International. 59: 208–224. Bibcode:2013EnInt..59..208L. doi:10.1016/j.envint.2013.06.012. ISSN 0160-4120. PMID 23838081.
Gadipelly C, Pérez-González A, Yadav GD, et al. (23 July 2014). "Pharmaceutical Industry Wastewater: Review of the Technologies for Water Treatment and Reuse". Industrial & Engineering Chemistry Research. 53 (29): 11571–11592. doi:10.1021/ie501210j. ISSN 0888-5885.
Anand U, Adelodun B, Cabreros C, et al. (1 December 2022). "Occurrence, transformation, bioaccumulation, risk and analysis of pharmaceutical and personal care products from wastewater: a review". Environmental Chemistry Letters. 20 (6): 3883–3904. Bibcode:2022EnvCL..20.3883A. doi:10.1007/s10311-022-01498-7. ISSN 1610-3661. PMC 9385088. PMID 35996725.

europa.eu (Global: 62^nd place; English: 100^th place)

ec.europa.eu

"Directive 2004/27/EC" (PDF). Official Journal of the European Union. 30 April 2004. L136. Archived from the original (PDF) on 29 April 2021.
"'Blockbuster medicine' is defined as being one which achieves annual revenues of over US$1 billion at global level." in European Commission, Pharmaceutical Sector Inquiry, Preliminary Report (DG Competition Staff Working Paper) Archived 26 August 2020 at the Wayback Machine, 28 November 2008, page 17 (pdf, 1.95 MB).

eur-lex.europa.eu

"Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use – Article 1". Published 31 March 2004. Accessed 17 August 2008. Archived 30 April 2021 at the Wayback Machine.

fda.gov (Global: 470^th place; English: 329^th place)

"Federal Food, Drug, and Cosmetic Act, SEC. 210". U.S. Food and Drug Administration. (g), (1), (B). Archived from the original on 12 May 2009. Retrieved 17 August 2008.
Research Cf (3 November 2018). "General Drug Categories". FDA.

fordham.edu (Global: 2,122^nd place; English: 1,444^th place)

ir.lawnet.fordham.edu

Ferreira L (2002). "Access to Affordable HIV/AIDS Drugs: The Human Rights Obligations of Multinational Pharmaceutical Corporations". Fordham Law Review. 71 (3): 1133–79. PMID 12523370. Archived from the original on 1 April 2014. Retrieved 20 January 2014.

genengnews.com (Global: low place; English: 6,199^th place)

Anson BD, Ma J, He JQ (1 May 2009). "Identifying Cardiotoxic Compounds". Genetic Engineering & Biotechnology News. TechNote. Vol. 29, no. 9. Mary Ann Liebert. pp. 34–35. ISSN 1935-472X. OCLC 77706455. Archived from the original on 21 September 2012. Retrieved 25 July 2009.

gov.uk (Global: 401^st place; English: 228^th place)

"PPRS: payment percentage 2017 – Details". GOV.UK. 23 December 2016. Archived from the original on 17 March 2017. Retrieved 16 March 2017.

gphaonline.org (Global: low place; English: low place)

"Misguided Policy on Patents". Generic Pharmaceutical Association (GPhA). Archived from the original on 28 September 2015. Retrieved 8 October 2015.

guernicamag.com (Global: low place; English: low place)

Whitney, Jake (February 2006). "Pharmaceutical Sales 101: Me-Too Drugs". Guernica. Archived from the original on 7 August 2008. Retrieved 31 July 2008.

healthaffairs.org (Global: low place; English: low place)

Spatz I, McGee N (25 November 2013). "Specialty Pharmaceuticals". Health Policy Briefs. Health Affairs. What's The Background?. Archived from the original on 6 September 2015. Retrieved 28 August 2015.

housefindings.com (Global: low place; English: low place)

Gina (21 July 2016). "Tips for Medication Safety". House Findings. Archived from the original on 14 September 2016. Retrieved 21 July 2016.

huffingtonpost.com (Global: 212^th place; English: 141^st place)

"Andrea Sloan Faces Pharma Firm With History of Indifference". Huffington Post. 26 September 2013. Archived from the original on 25 December 2013. Retrieved 24 December 2013.

medthority.com (Global: low place; English: low place)

https://www.medthority.com Archived 8 January 2023 at the Wayback Machine database of prescription pharmaceutical products including drug classifications https://www.medthority.com/drugs/

merckmanuals.com (Global: 4,016^th place; English: 3,703^rd place)

"Drug Administration - Drugs". Merck Manual Consumer Version. Retrieved 7 August 2025.

nature.com (Global: 207^th place; English: 347^th place)

Charlotte Harrison Patent watch Nature Reviews Drug Discovery 12, 336–337 (2013)

nih.gov (Global: 5^th place; English: 5^th place)

pubmed.ncbi.nlm.nih.gov

Qato DM, Wilder J, Schumm L, et al. (1 April 2016). "Changes in prescription and over-the-counter medication and dietary supplement use among older adults in the united states, 2005 vs 2011". JAMA Internal Medicine. 176 (4): 473–482. doi:10.1001/jamainternmed.2015.8581. PMC 5024734. PMID 26998708.
Steven M. Paul, Daniel S. Mytelka, Christopher T. Dunwiddie, et al. (2010). "How to improve R&D productivity: the pharmaceutical industry's grand challenge". Nature Reviews Drug Discovery. 9 (3): 203–214. Bibcode:2010NRvDD...9..203P. doi:10.1038/nrd3078. PMID 20168317. S2CID 1299234.
Strovel J, Sittampalam S, Coussens NP, et al. (1 July 2016). "Early Drug Discovery and Development Guidelines: For Academic Researchers, Collaborators, and Start-up Companies". Assay Guidance Manual. Eli Lilly & Company and the National Center for Advancing Translational Sciences. PMID 22553881. Archived from the original on 19 April 2020. Retrieved 20 May 2017.
Dean B, Barber N, Schachter M (December 2000). "What is a prescribing error?". Qual Health Care. 9 (4): 232–7. doi:10.1136/qhc.9.4.232. PMC 1743540. PMID 11101708.
Fonseca Md, Shadlen KC (20 April 2017). "Promoting and regulating generic medicines: Brazil in comparative perspective". Revista Panamericana de Salud Pública. 41 (e5): 2. PMC 6612747. PMID 28444005.
Kesselheim AS, Avorn J, Sarpatwari A (23 August 2016). "The High Cost of Prescription Drugs in the United States". JAMA. 316 (8): 858–71. doi:10.1001/jama.2016.11237. PMID 27552619. S2CID 19317308.
Scannell JW, Blanckley A, Boldon H, et al. (1 March 2012). "Diagnosing the decline in pharmaceutical R&D efficiency". Nature Reviews Drug Discovery. 11 (3): 191–200. Bibcode:2012NRvDD..11..191S. doi:10.1038/nrd3681. ISSN 1474-1776. PMID 22378269. S2CID 3344476.
Dowling HF (June 1972). "Frustration and foundation. Management of pneumonia before antibiotics". JAMA. 220 (10): 1341–5. doi:10.1001/jama.1972.03200100053011. PMID 4553966.
Everett N, Gabra M (8 August 2014). "The pharmacology of medieval sedatives: the "Great Rest" of the Antidotarium Nicolai". Journal of Ethnopharmacology. 155 (1): 443–449. doi:10.1016/j.jep.2014.05.048. ISSN 1872-7573. PMID 24905867.
Banta D.H. (2001). "Worldwide Interest in Global Access to Drugs". Journal of the American Medical Association. 285 (22): 2844–46. doi:10.1001/jama.285.22.2844-JMN0613-3-1. PMID 11401589.
Ferreira L (2002). "Access to Affordable HIV/AIDS Drugs: The Human Rights Obligations of Multinational Pharmaceutical Corporations". Fordham Law Review. 71 (3): 1133–79. PMID 12523370. Archived from the original on 1 April 2014. Retrieved 20 January 2014.
Barton J.H., Emanuel E.J. (2005). "The Patents-Based Pharmaceutical Development Process: Rationale, Problems and Potential Reforms". Journal of the American Medical Association. 294 (16): 2075–82. doi:10.1001/jama.294.16.2075. PMID 16249422. S2CID 10277752.
Patel M, Kumar R, Kishor K, et al. (27 March 2019). "Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods". Chemical Reviews. 119 (6): 3510–3673. doi:10.1021/acs.chemrev.8b00299. ISSN 0009-2665. PMID 30830758.
Liu JL, Wong MH (1 September 2013). "Pharmaceuticals and personal care products (PPCPs): A review on environmental contamination in China". Environment International. 59: 208–224. Bibcode:2013EnInt..59..208L. doi:10.1016/j.envint.2013.06.012. ISSN 0160-4120. PMID 23838081.
Anand U, Adelodun B, Cabreros C, et al. (1 December 2022). "Occurrence, transformation, bioaccumulation, risk and analysis of pharmaceutical and personal care products from wastewater: a review". Environmental Chemistry Letters. 20 (6): 3883–3904. Bibcode:2022EnvCL..20.3883A. doi:10.1007/s10311-022-01498-7. ISSN 1610-3661. PMC 9385088. PMID 35996725.

ncbi.nlm.nih.gov

Qato DM, Wilder J, Schumm L, et al. (1 April 2016). "Changes in prescription and over-the-counter medication and dietary supplement use among older adults in the united states, 2005 vs 2011". JAMA Internal Medicine. 176 (4): 473–482. doi:10.1001/jamainternmed.2015.8581. PMC 5024734. PMID 26998708.
Strovel J, Sittampalam S, Coussens NP, et al. (1 July 2016). "Early Drug Discovery and Development Guidelines: For Academic Researchers, Collaborators, and Start-up Companies". Assay Guidance Manual. Eli Lilly & Company and the National Center for Advancing Translational Sciences. PMID 22553881. Archived from the original on 19 April 2020. Retrieved 20 May 2017.
Dean B, Barber N, Schachter M (December 2000). "What is a prescribing error?". Qual Health Care. 9 (4): 232–7. doi:10.1136/qhc.9.4.232. PMC 1743540. PMID 11101708.
Fonseca Md, Shadlen KC (20 April 2017). "Promoting and regulating generic medicines: Brazil in comparative perspective". Revista Panamericana de Salud Pública. 41 (e5): 2. PMC 6612747. PMID 28444005.
Anand U, Adelodun B, Cabreros C, et al. (1 December 2022). "Occurrence, transformation, bioaccumulation, risk and analysis of pharmaceutical and personal care products from wastewater: a review". Environmental Chemistry Letters. 20 (6): 3883–3904. Bibcode:2022EnvCL..20.3883A. doi:10.1007/s10311-022-01498-7. ISSN 1610-3661. PMC 9385088. PMID 35996725.

nlm.nih.gov

"Greek Medicine – Dioscorides". www.nlm.nih.gov. Archived from the original on 9 November 2013. Retrieved 16 February 2021.

nytimes.com (Global: 7^th place; English: 7^th place)

Kolata G (12 September 1994). "F.D.A. Debate on Speedy Access to AIDS Drugs Is Reopening". The New York Times. Archived from the original on 1 July 2017.

pmprb-cepmb.gc.ca (Global: low place; English: low place)

"Schedule 7 – International Therapeutic Class Comparison Test". 30 April 2014. Archived from the original on 17 April 2018. Retrieved 16 March 2017.

reshafim.org.il (Global: low place; English: low place)

"Ancient Egypt: The Kahun medical papyrus". www.reshafim.org.il. Archived from the original on 13 January 2019.

semanticscholar.org (Global: 15^th place; English: 8^th place)

api.semanticscholar.org

Steven M. Paul, Daniel S. Mytelka, Christopher T. Dunwiddie, et al. (2010). "How to improve R&D productivity: the pharmaceutical industry's grand challenge". Nature Reviews Drug Discovery. 9 (3): 203–214. Bibcode:2010NRvDD...9..203P. doi:10.1038/nrd3078. PMID 20168317. S2CID 1299234.
Kesselheim AS, Avorn J, Sarpatwari A (23 August 2016). "The High Cost of Prescription Drugs in the United States". JAMA. 316 (8): 858–71. doi:10.1001/jama.2016.11237. PMID 27552619. S2CID 19317308.
Scannell JW, Blanckley A, Boldon H, et al. (1 March 2012). "Diagnosing the decline in pharmaceutical R&D efficiency". Nature Reviews Drug Discovery. 11 (3): 191–200. Bibcode:2012NRvDD..11..191S. doi:10.1038/nrd3681. ISSN 1474-1776. PMID 22378269. S2CID 3344476.
Helene S (2010). "EU Compassionate Use Programmes (CUPs): Regulatory Framework and Points to Consider before CUP Implementation". Pharm Med. 24 (4): 223–229. doi:10.1007/bf03256820. S2CID 31439802.
Barton J.H., Emanuel E.J. (2005). "The Patents-Based Pharmaceutical Development Process: Rationale, Problems and Potential Reforms". Journal of the American Medical Association. 294 (16): 2075–82. doi:10.1001/jama.294.16.2075. PMID 16249422. S2CID 10277752.

springerpub.com (Global: low place; English: low place)

connect.springerpub.com

"Drug Names, Mechanisms, Descriptions, and Contraindications | Springer Publishing". connect.springerpub.com. Retrieved 7 August 2025.

unep.org (Global: 4,173^rd place; English: 3,588^th place)

Environment UN (17 September 2020). "Environmentally Persistent Pharmaceutical Pollutants (EPPPs)". UNEP – UN Environment Programme. Retrieved 7 January 2024.

web.archive.org (Global: 1^st place; English: 1^st place)

"Federal Food, Drug, and Cosmetic Act, SEC. 210". U.S. Food and Drug Administration. (g), (1), (B). Archived from the original on 12 May 2009. Retrieved 17 August 2008.
"Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use – Article 1". Published 31 March 2004. Accessed 17 August 2008. Archived 30 April 2021 at the Wayback Machine.
"Medication Definition & Meaning". Britannica Dictionary. Archived from the original on 31 March 2022. Retrieved 31 March 2022.
"Definition of medication". National Cancer Institute. 2 February 2011. Archived from the original on 29 November 2022. Retrieved 24 November 2022.
"Directive 2004/27/EC" (PDF). Official Journal of the European Union. 30 April 2004. L136. Archived from the original (PDF) on 29 April 2021.
FDA, "Drugs@FDA Glossary of Terms". Archived 8 January 2023 at the Wayback Machine.
https://www.medthority.com Archived 8 January 2023 at the Wayback Machine database of prescription pharmaceutical products including drug classifications https://www.medthority.com/drugs/
Spatz I, McGee N (25 November 2013). "Specialty Pharmaceuticals". Health Policy Briefs. Health Affairs. What's The Background?. Archived from the original on 6 September 2015. Retrieved 28 August 2015.
Anson BD, Ma J, He JQ (1 May 2009). "Identifying Cardiotoxic Compounds". Genetic Engineering & Biotechnology News. TechNote. Vol. 29, no. 9. Mary Ann Liebert. pp. 34–35. ISSN 1935-472X. OCLC 77706455. Archived from the original on 21 September 2012. Retrieved 25 July 2009.
Strovel J, Sittampalam S, Coussens NP, et al. (1 July 2016). "Early Drug Discovery and Development Guidelines: For Academic Researchers, Collaborators, and Start-up Companies". Assay Guidance Manual. Eli Lilly & Company and the National Center for Advancing Translational Sciences. PMID 22553881. Archived from the original on 19 April 2020. Retrieved 20 May 2017.
Gina (21 July 2016). "Tips for Medication Safety". House Findings. Archived from the original on 14 September 2016. Retrieved 21 July 2016.
"PPRS: payment percentage 2017 – Details". GOV.UK. 23 December 2016. Archived from the original on 17 March 2017. Retrieved 16 March 2017.
"Schedule 7 – International Therapeutic Class Comparison Test". 30 April 2014. Archived from the original on 17 April 2018. Retrieved 16 March 2017.
"'Blockbuster medicine' is defined as being one which achieves annual revenues of over US$1 billion at global level." in European Commission, Pharmaceutical Sector Inquiry, Preliminary Report (DG Competition Staff Working Paper) Archived 26 August 2020 at the Wayback Machine, 28 November 2008, page 17 (pdf, 1.95 MB).
Whitney, Jake (February 2006). "Pharmaceutical Sales 101: Me-Too Drugs". Guernica. Archived from the original on 7 August 2008. Retrieved 31 July 2008.
Stork W (20 June 2005). "Top Pharmaceuticals: Prontosil". Chemical & Engineering News. Vol. 83, no. 25. Archived from the original on 13 October 2008. Retrieved 30 May 2014.
"Ancient Egypt: The Kahun medical papyrus". www.reshafim.org.il. Archived from the original on 13 January 2019.
"Greek Medicine – Dioscorides". www.nlm.nih.gov. Archived from the original on 9 November 2013. Retrieved 16 February 2021.
Kolata G (12 September 1994). "F.D.A. Debate on Speedy Access to AIDS Drugs Is Reopening". The New York Times. Archived from the original on 1 July 2017.
"Andrea Sloan Faces Pharma Firm With History of Indifference". Huffington Post. 26 September 2013. Archived from the original on 25 December 2013. Retrieved 24 December 2013.
"In cancer drug battle, both sides appeal to ethics". CNN. 20 September 2013. Archived from the original on 25 December 2013. Retrieved 24 December 2013.
"The Selection and Use of Essential Medicines – WHO Technical Report Series, No. 914: 4. Other outstanding technical issues: 4.2 Description of essential medicines". Apps.who.int. 14 April 2016. Archived from the original on 1 February 2014. Retrieved 25 June 2016.
Kowalksy SP (2013). "Patent Landscape Analysis of Healthcare Innovations" (PDF). The Franklin Pierce Center for Intellectual Property. University of New Hampshire School of Law. Archived from the original (PDF) on 4 March 2016.
Ferreira L (2002). "Access to Affordable HIV/AIDS Drugs: The Human Rights Obligations of Multinational Pharmaceutical Corporations". Fordham Law Review. 71 (3): 1133–79. PMID 12523370. Archived from the original on 1 April 2014. Retrieved 20 January 2014.
"Misguided Policy on Patents". Generic Pharmaceutical Association (GPhA). Archived from the original on 28 September 2015. Retrieved 8 October 2015.

who.int (Global: 213^th place; English: 314^th place)

apps.who.int

"The Selection and Use of Essential Medicines – WHO Technical Report Series, No. 914: 4. Other outstanding technical issues: 4.2 Description of essential medicines". Apps.who.int. 14 April 2016. Archived from the original on 1 February 2014. Retrieved 25 June 2016.

worldcat.org (Global: 4^th place; English: 4^th place)

search.worldcat.org

Anson BD, Ma J, He JQ (1 May 2009). "Identifying Cardiotoxic Compounds". Genetic Engineering & Biotechnology News. TechNote. Vol. 29, no. 9. Mary Ann Liebert. pp. 34–35. ISSN 1935-472X. OCLC 77706455. Archived from the original on 21 September 2012. Retrieved 25 July 2009.
van Wormer KS, Link RJ (18 March 2015). Social welfare policy for a sustainable future : the U.S. in global context. Los Angeles: SAGE. ISBN 978-1-4522-4031-2. OCLC 899880624.
Scannell JW, Blanckley A, Boldon H, et al. (1 March 2012). "Diagnosing the decline in pharmaceutical R&D efficiency". Nature Reviews Drug Discovery. 11 (3): 191–200. Bibcode:2012NRvDD..11..191S. doi:10.1038/nrd3681. ISSN 1474-1776. PMID 22378269. S2CID 3344476.
Everett N, Gabra M (8 August 2014). "The pharmacology of medieval sedatives: the "Great Rest" of the Antidotarium Nicolai". Journal of Ethnopharmacology. 155 (1): 443–449. doi:10.1016/j.jep.2014.05.048. ISSN 1872-7573. PMID 24905867.
Richmond EK, Grace MR, Kelly JJ, et al. (1 January 2017). "Pharmaceuticals and personal care products (PPCPs) are ecological disrupting compounds (EcoDC)". Elementa: Science of the Anthropocene. 5 66. Bibcode:2017EleSA...5Q..66R. doi:10.1525/elementa.252. ISSN 2325-1026.
Ebele AJ, Abou-Elwafa Abdallah M, Harrad S (1 March 2017). "Pharmaceuticals and personal care products (PPCPs) in the freshwater aquatic environment". Emerging Contaminants. 3 (1): 1–16. doi:10.1016/j.emcon.2016.12.004. ISSN 2405-6650.
Patel M, Kumar R, Kishor K, et al. (27 March 2019). "Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods". Chemical Reviews. 119 (6): 3510–3673. doi:10.1021/acs.chemrev.8b00299. ISSN 0009-2665. PMID 30830758.
Liu JL, Wong MH (1 September 2013). "Pharmaceuticals and personal care products (PPCPs): A review on environmental contamination in China". Environment International. 59: 208–224. Bibcode:2013EnInt..59..208L. doi:10.1016/j.envint.2013.06.012. ISSN 0160-4120. PMID 23838081.
Gadipelly C, Pérez-González A, Yadav GD, et al. (23 July 2014). "Pharmaceutical Industry Wastewater: Review of the Technologies for Water Treatment and Reuse". Industrial & Engineering Chemistry Research. 53 (29): 11571–11592. doi:10.1021/ie501210j. ISSN 0888-5885.
Anand U, Adelodun B, Cabreros C, et al. (1 December 2022). "Occurrence, transformation, bioaccumulation, risk and analysis of pharmaceutical and personal care products from wastewater: a review". Environmental Chemistry Letters. 20 (6): 3883–3904. Bibcode:2022EnvCL..20.3883A. doi:10.1007/s10311-022-01498-7. ISSN 1610-3661. PMC 9385088. PMID 35996725.

Medication (English Wikipedia)

accesstopharmaceuticals.org (Global: low place; English: low place)

acs.org (Global: 865th place; English: 887th place)

pubs.acs.org

adsabs.harvard.edu (Global: 14th place; English: 9th place)

ui.adsabs.harvard.edu

britannica.com (Global: 37th place; English: 64th place)

cancer.gov (Global: 1,906th place; English: 1,649th place)

cnn.com (Global: 36th place; English: 26th place)

doi.org (Global: 2nd place; English: 2nd place)

europa.eu (Global: 62nd place; English: 100th place)

ec.europa.eu

eur-lex.europa.eu

fda.gov (Global: 470th place; English: 329th place)

fordham.edu (Global: 2,122nd place; English: 1,444th place)

ir.lawnet.fordham.edu

genengnews.com (Global: low place; English: 6,199th place)

gov.uk (Global: 401st place; English: 228th place)

gphaonline.org (Global: low place; English: low place)

guernicamag.com (Global: low place; English: low place)

healthaffairs.org (Global: low place; English: low place)

housefindings.com (Global: low place; English: low place)

huffingtonpost.com (Global: 212th place; English: 141st place)

medthority.com (Global: low place; English: low place)

merckmanuals.com (Global: 4,016th place; English: 3,703rd place)

nature.com (Global: 207th place; English: 347th place)

nih.gov (Global: 5th place; English: 5th place)

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

nlm.nih.gov

nytimes.com (Global: 7th place; English: 7th place)

pmprb-cepmb.gc.ca (Global: low place; English: low place)

reshafim.org.il (Global: low place; English: low place)

semanticscholar.org (Global: 15th place; English: 8th place)

api.semanticscholar.org

springerpub.com (Global: low place; English: low place)

connect.springerpub.com

unep.org (Global: 4,173rd place; English: 3,588th place)

web.archive.org (Global: 1st place; English: 1st place)

who.int (Global: 213th place; English: 314th place)

apps.who.int

worldcat.org (Global: 4th place; English: 4th place)

search.worldcat.org

acs.org (Global: 865^th place; English: 887^th place)

adsabs.harvard.edu (Global: 14^th place; English: 9^th place)

britannica.com (Global: 37^th place; English: 64^th place)

cancer.gov (Global: 1,906^th place; English: 1,649^th place)

cnn.com (Global: 36^th place; English: 26^th place)

doi.org (Global: 2^nd place; English: 2^nd place)

europa.eu (Global: 62^nd place; English: 100^th place)

fda.gov (Global: 470^th place; English: 329^th place)

fordham.edu (Global: 2,122^nd place; English: 1,444^th place)

genengnews.com (Global: low place; English: 6,199^th place)

gov.uk (Global: 401^st place; English: 228^th place)

huffingtonpost.com (Global: 212^th place; English: 141^st place)

merckmanuals.com (Global: 4,016^th place; English: 3,703^rd place)

nature.com (Global: 207^th place; English: 347^th place)

nih.gov (Global: 5^th place; English: 5^th place)

nytimes.com (Global: 7^th place; English: 7^th place)

semanticscholar.org (Global: 15^th place; English: 8^th place)

unep.org (Global: 4,173^rd place; English: 3,588^th place)

web.archive.org (Global: 1^st place; English: 1^st place)

who.int (Global: 213^th place; English: 314^th place)

worldcat.org (Global: 4^th place; English: 4^th place)